Document Preview Unavailable
The Use of Cost Effectiveness Analyses by PharmaceuticalBenefit Managers
Grabowski, Henry G; Mullins, C Daniel. IDEAS Working Paper Series from RePEc, 1995.You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library